[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-435390-105":59,"doc-detail-435390-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","kdigo-clinical-practice-guideline-on-the-evaluation-and-management-of-candidates-for-kidney-transplantation","KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","","April 2020 KDIGO Clinical Practice Guideline provides structured recommendations for evaluating and managing candidates for kidney transplantation. The guideline covers access to transplantation, age considerations, pediatric issues, and psychosocial assessment, with sections addressing adherence, tobacco use, surgical issues including obesity, and comorbidities such as diabetes, infections, malignancy, and major organ systems. It also includes cause of end-stage kidney disease, immunological assessment, and bone and mineral metabolism, supported by methods for guideline development, reference keys, and summarised recommendation statements.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kdigo-clinical-practice-guideline-on-the-evaluation-and-management-of-candidates-for-kidney-transplantation/435390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kdigo-clinical-practice-guideline-on-the-evaluation-and-management-of-candidates-for-kidney-transplantation/435390.png","ImageObject",300,407,{"name":92,"@type":93},"dbqoiu","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What topics are included in the guideline for kidney transplant candidates?","Question",{"text":113,"@type":114},"It covers access to transplantation, age and pediatric issues, psychosocial assessment, adherence, tobacco, surgical issues including obesity, diabetes, infections, malignancy, pulmonary and cardiac disease, vascular disease, neurologic disease, gastrointestinal and liver disease, hematologic disorders, bone and mineral metabolism, and immunological assessment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Where can readers find the guideline’s recommendation summaries and development methods?",{"text":118,"@type":114},"The table of contents lists “Summary of Recommendation Statements” and “Methods for Guideline Development” within the main guideline section.",{"name":120,"@type":111,"acceptedAnswer":121},"Does the guideline address immunological assessment and end-stage kidney disease causes?",{"text":122,"@type":114},"Yes. It includes a dedicated section for “Cause of End-Stage Kidney Disease (ESKD)” and another for “Immunological Assessment,” alongside other clinical risk and assessment domains.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},435390,1790717342,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},3985747862462,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","April 2020 ■ Volume 104 ■ Number 4S  \nTransplantation®  \nKDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation  \n [www.transplantjournal.com](www.transplantjournal.com)  \nApril 2020 ■ Volume 104 ■ Number 4S  \nTransplantation®  \nContents  \nDisclaimer ...................................................................................................................................... S1  \nKDIGO Executive Committee ..................................................................................................... S2  \nWork Group Membership ............................................................................................................ S3  \nPreface ........................................................................................................................................... S4  \nReference Keys............................................................................................................................. S6  \nKDIGO CKD Nomenclature ......................................................................................................... S7  \nConversion Factors ...................................................................................................................... S8  \nAbbreviations and Acronyms...................................................................................................... S9  \nKDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.................................................................................... S11  \nSummary of Recommendation Statements ............................................................................. S11  \nMethods for Guideline Development ........................................................................................ S22  \nSection 1: Access to Transplantation ....................................................................................... S33  \nSection 2: Age ............................................................................................................................... S35  \nSection 3: Pediatric Issues ......................................................................................................... S36  \nSection 4: Psychosocial Assessment ....................................................................................... S37  \nSection 5: Adherence .................................................................................................................. S39  \nSection 6: Tobacco ....................................................................................................................... S41  \nSection 7: Surgical Issues including Obesity .......................................................................... S43  \nSection 8: Diabetes ...................................................................................................................... S46  \nSection 9: Cause of End-Stage Kidney Disease (ESKD) ....................................................... S47  \nSection 10: Infections.................................................................................................................. S55  \nSection 11: Malignancy ............................................................................................................... S63  \nSection 12: Pulmonary Disease ................................................................................................. S67  \nSection 13: Cardiac Disease ...................................................................................................... S68  \nSection 14: Peripheral Arterial Disease (PAD) ........................................................................ S72  \nSection 15: Neurologic Disease................................................................................................. S73  \nSection 16: Gastronintestinal and Liver Disease ...............................................","cbCaia4u7xEdwGLY","https://ap.wps.com/l/cbCaia4u7xEdwGLY","pdf",5010375,106,"English","# Disclaimer\n# KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation\n## Summary of Recommendation Statements\n## Methods for Guideline Development\n## Section 1: Access to Transplantation\n## Section 2: Age\n## Section 3: Pediatric Issues\n## Section 4: Psychosocial Assessment\n## Section 5: Adherence\n## Section 6: Tobacco\n## Section 7: Surgical Issues including Obesity\n## Section 8: Diabetes\n## Section 9: Cause of End-Stage Kidney Disease (ESKD)\n## Section 10: Infections\n## Section 11: Malignancy\n## Section 12: Pulmonary Disease\n## Section 13: Cardiac Disease\n## Section 14: Peripheral Arterial Disease (PAD)\n## Section 15: Neurologic Disease\n## Section 16: Gastronintestinal and Liver Disease\n## Section 17: Hematologic Disorders\n## Section 18: Bone and Mineral Metabolism\n## Section 19: Immunological Assessment\n# References","[{\"question\":\"What topics are included in the guideline for kidney transplant candidates?\",\"answer\":\"It covers access to transplantation, age and pediatric issues, psychosocial assessment, adherence, tobacco, surgical issues including obesity, diabetes, infections, malignancy, pulmonary and cardiac disease, vascular disease, neurologic disease, gastrointestinal and liver disease, hematologic disorders, bone and mineral metabolism, and immunological assessment.\"},{\"question\":\"Where can readers find the guideline’s recommendation summaries and development methods?\",\"answer\":\"The table of contents lists “Summary of Recommendation Statements” and “Methods for Guideline Development” within the main guideline section.\"},{\"question\":\"Does the guideline address immunological assessment and end-stage kidney disease causes?\",\"answer\":\"Yes. It includes a dedicated section for “Cause of End-Stage Kidney Disease (ESKD)” and another for “Immunological Assessment,” alongside other clinical risk and assessment domains.\"}]","KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation | PDF",1790673442,267]